Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 8, 2016

View Archived Issues

Mitsubishi Tanabe profiles pipeline progress of second quarter of fiscal 2016

Lundbeck updates key developments of third quarter 2016

AZD-8931 does not improve progression-free survival in wild-type colorectal cancer patients

NIH award supports TherapyX's testing of IL10-NanoCap

NICE recommends Eisai's eribulin for breast cancer

Ascend Biopharmaceuticals reports interim results of phase I/IIa study on ASN-002

Study finds pharmacokinetic equivalence between Neulasta pegfilgrastim and Mylan/Biocon biosimilar

FDA accepts BLA for human rabies immunoglobulin

First-in-human study of Mucosis' SynGEM begins

GeoVax and ViaMune to codevelop cancer immunotherapy program

The Medicines Company discontinues development of MDCO-216

Amgen presents pipeline highlights of third quarter 2016

Vertex Pharmaceuticals reports positive phase III results on Orkambi

CHERISH study of Spinraza in later-onset SMA meets primary endpoint

TGFB1 may be behind coronary artery disease with glatiramer acetate treatment

FDA grants several orphan drug designations to APX-001

Scientists develop a new animal model for BBSOAS

H. Lundbeck patents PDE1 inhibitors

Guangdong Zhongsheng Pharmaceutical describes thromboxane synthase inhibitors

Guangzhou Maxinovel Pharmaceuticals develops ALK tyrosine kinase receptor inhibitors

Shire offers overview of third quarter 2016

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...